Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-05-28 16:19:05 ET · period of report 2026-05-26 · accession 0000905148-26-002724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-28 16:19 | 2026-05-26 | RIGL | Ali-Jackson Kamil | Dir | S - Sale | $29.17 | -2,500 | 12.6K | -17% | -$72.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | S | D | 2,500 | $29.17 | 12,625 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. |